con't
"As a result, all of the participating patients were able to avoid going through more dangerous, taxing, treatments.
'[The results] enabled us to omit both chemoradiotherapy and surgery and to proceed with observation alone,' researchers wrote.
Surgery and radiation can have permanent effects on fertility, sexual health, and bowel and bladder function.
'The implications for quality of life are substantial, especially among patients in whom standard treatment would affect childbearing potential.'
The treatment came with limited negative side-effects as well. Around 20 percent of participants felt an adverse effect, but they were easily managed.
While this study is ground breaking, and looks like doctors may have stumbled onto a cancer cure, they know it is too early to declare this a miracle drug.
'Although the results of our study are promising, especially given that 12 consecutive patients all had a clinical complete response, the study is small and represents the experience of a single institution,' they wrote.
'These findings must be reproduced in a larger prospective cohort that balances academic and community practices and ensures the participation of patients from a diverse set of racial and ethnic backgrounds.'"
Dostarlimab, a monoclonal antibody drug, smashed expectations in a recent trial run by Memorial Sloan Kettering hospital in New York, sponsored by pharmaceutical giant GlaxoSmithKline (GSK).